Status | Study |
Completed |
Study Name: Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients Condition: Renal Dialysis Date: 2008-06-24 Interventions: Drug: Levamisole Drug: Placebo |
Completed |
Study Name: PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) Condition: Clostridium Infections Diarrhea Date: 2007-05-01 Interventions: Drug: PAR-101/OPT-80 capsules |
Completed |
Study Name: Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes Condition: Clostridium Infections Date: 2007-03-08 |
Terminated |
Study Name: Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease Condition: Clostridium Infections Date: 2006-10-05 Interventions: Drug: Nitazoxanide One nitazox |
Completed |
Study Name: Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease Condition: Clostridium Infections Date: 2006-07-07 Interventions: Biological: GS-CDA1 one dose I |
Completed |
Study Name: Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients Condition: Diarrhea Clostridium Infections Date: 2006-05-17 Interventions: Dietary Supplement: Lactobacillus acidophilus CL1285 and Lactobacillus casei |
Completed |
Study Name: Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018) Condition: Clostridium Infections Diarrhea Date: 2006-04-13 Interventions: Drug: Fidaxomicin 200 mg oral |
Completed |
Study Name: A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) Condition: Clostridium Infections Diarrhea Date: 2005-12-22 Interventions: Drug: Rifaximin (Xifaxan) |
Completed |
Study Name: Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers Condition: Clostridium Infections Date: 2005-09-16 Interventions: Biological: Vaccine diluent buffer (Placebo) |
Completed |
Study Name: Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine Condition: Pneumococcal Infections Date: 2005-09-09 Interventions: Biological: Tetanus-diphtheria toxoids (Td) |